Early Assessment for Prevention of Breast Cancer-Related Lymphedema

Breast cancer-related lymphedema (BCRL) is an incurable, disfiguring, progressive complication occurring after breast cancer treatment. BCRL is difficult to treat and is characterized by significant and persistent swelling. Lymphedema is the most common morbidity resulting from breast cancer treatment. Therefore, BCRL should be assessed during clinic visits in oncology and primary care settings. An evidence-based algorithm for early detection of BCRL in primary care settings is presented with explanations of the protocol elements.